ALSE Recent News Concise Analysis of the Internat
Post# of 6
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
Concise Analysis of the International Radiopharmaceuticals Market M2 - Fri Feb 14, 5:11AM CST
Nova Scotia Power approves preferred share dividend of CAD0.37 M2 - Thu Feb 06, 5:21AM CST
Nova Scotia Power Inc. Approves Preferred ShareQuarterly Dividend Business Wire - Wed Feb 05, 2:14PM CST
Navidea Biopharmaceuticals Announces Issuance of New U.S. Patent Covering Formulation for Neuroimaging Agent, NAV5001 Business Wire - Thu Nov 14, 7:30AM CST
Nova Scotia Power declares preferred dividend of USD0.36875 per share for Q4 M2 - Thu Nov 07, 3:33AM CST
Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers M2 - Fri Aug 02, 9:34AM CDT
Nova Scotia Power Inc. Issues $300 Million ofMedium Term Notes Business Wire - Fri Jul 19, 8:59AM CDT
Nova Scotia Power's board approves USD0.36875 quarterly preferred share dividend M2 - Mon Jul 08, 4:26AM CDT
Nova Scotia Power announces quarterly dividend of USD0.36875 per share on its preferred stock M2 - Mon Jul 08, 3:06AM CDT
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)